Sen. Grassley Wants An Accounting of Pharmaceutical and Medical Device Company Contributions

Continuing his “ongoing probe into conflicts of interest,” Senator Chuck Grassley this week sent letters to the American Medical Association, Alzheimer’s Association, the American Cancer Society and 30 other disease and medical advocacy organizations asking them to provide details about the amount of money that they and their directors receive from drug and device makers.

Read more, including Senator Grassley’s letter, in Thomas Sullivan’s Policy and Medicine Blog.

Related Posts

Congressional Agreement Reached on 2026 Health Spending

Legal Group to FDA: Pursue Drug Ad Restrictions, Receive Constitutional Challenge

FDA’s Agents of Chaos Overwhelming Control